Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
PICU Admission Lactate and Central Venous Oxymetry Study
Terminated
- Conditions
- Shock
- First Posted Date
- 2012-09-28
- Last Posted Date
- 2017-10-02
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01696175
- Locations
- π³π±
RUNMC, Nijmegen, Netherlands
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
Phase 1
Completed
- Conditions
- Herpes Simplex Virus InfectionVaricella Zoster Virus Infection
- Interventions
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01689285
- Locations
- π³π±
Radboud University Medical Center, Nijmegen, Netherlands
Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
Phase 1
Completed
- Conditions
- Melanoma
- Interventions
- Biological: PDC or myDC
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT01690377
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Palatability Testing of a New Paediatric Formulation of Valacyclovir
Phase 4
Completed
- Conditions
- Varicella Zoster Virus InfectionHerpes Simplex Virus Infection
- Interventions
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 41
- Registration Number
- NCT01682109
- Locations
- π³π±
Radboud University Medical Center, Nijmegen, Netherlands
Hd-bronchoscopy, Comparison to Standard White Light and Autofluorescence Bronchoscopy
Completed
- Conditions
- Cancer
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT01676012
- Locations
- π³π±
Radboud University Medical Center Nijmegen, Nijmegen, Geert Grooteplein 10, Netherlands
Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites
Not Applicable
Completed
- Conditions
- Malaria, Falciparum
- Interventions
- Biological: Heterologous challengeDrug: Malarone treatment
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT01660854
- Locations
- π³π±
Leiden University Medical Centre, Leiden, Netherlands
Exercise Test and Cardiac Injury
Not Applicable
Completed
- Conditions
- Cardiovascular Disease
- Interventions
- Other: remote ischemic preconditioning (RIPC)
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01660828
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Effect of Tea on Endothelial Function and Ischaemia-reperfusion Injury
Completed
- Conditions
- Ischaemia Reperfusion Injury
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT01660516
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome
Not Applicable
Completed
- Conditions
- Postcancer FatigueChronic Fatigue Syndrome
- Interventions
- Biological: Seasonal influenza vaccination
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2012-07-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT01651754
- Locations
- π³π±
University Medical Centre Nijmegen st Radboud, Nijmegen, Netherlands
The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis
Phase 3
Completed
- Conditions
- SepsisSeptic Shock
- Interventions
- Other: Saline 0.9%Drug: Interferon-gamma, Recombinant
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT01649921
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Β© Copyright 2025. All Rights Reserved by MedPath